Craneware plc (CRW.L) Bundle
Founded in 1999, Craneware plc - now trading and operating as The Craneware Group - has built a reputation as a leading provider of revenue integrity solutions for U.S. healthcare providers, combining a comprehensive software suite and the Trisus® cloud ecosystem of data, revenue intelligence, margin intelligence and advanced analytics to drive measurable financial and operational impact; strategic moves such as the July 2021 acquisitions of Sentry Data Systems and Agilum Healthcare Intelligence expanded its 340B and broader revenue management capabilities, the March 2022 rebrand unified its market presence, and as of December 2024 the company reported a 10% year‑on‑year revenue increase, surpassing $100 million for the first time in a six‑month period - all anchored by a mission to transform the business of healthcare so providers can deliver quality care without financial constraint, a vision to be the trusted partner that sustains strong operational and financial performance, and core values - Be Authentic, Demonstrate Integrity, Provide Excellent Service, Work Hard to the Highest Quality, Enjoy the Challenge - that shape culture, product development and recognitions like the annual Framework Award
Craneware plc (CRW.L) - Intro
Craneware plc (CRW.L), founded in 1999, is a specialist provider of revenue integrity and financial performance solutions for healthcare providers, with a primary focus on the United States market. The business combines software, analytics, and domain expertise to reduce revenue leakage, optimize reimbursement, and improve operational efficiency across hospitals and health systems.- Founded: 1999
- Primary market: United States healthcare providers
- Key capability: Revenue integrity, margin intelligence, 340B program management
- Flagship platform: Trisus® cloud ecosystem (data, revenue intelligence, margin intelligence, advanced analytics)
- Ensure healthcare organisations maximize legitimate revenue capture while reducing administrative burden through trusted, evidence-driven software and services.
- Deliver measurable, recurring financial improvement and operational clarity for customers via integrated data and analytics.
- Be the global standard for healthcare revenue integrity and margin intelligence, enabling sustainably funded care through transparent, data-led decisions.
- Unify disparate revenue-focused functions into a single, cloud-native ecosystem (Trisus®) that scales across commercial and public healthcare sectors.
- Customer outcomes: Prioritise measurable financial and operational results for providers.
- Integrity: Maintain rigorous accuracy, compliance, and trust in financial reporting and analytics.
- Innovation: Invest in cloud, analytics, and product integrations to solve evolving revenue challenges.
- Collaboration: Partner with providers, payers, and technology allies to drive shared success.
- July 2021 acquisitions: Sentry Data Systems and Agilum Healthcare Intelligence - expanded 340B capabilities and population health-aligned margin intelligence.
- March 2022 rebrand: Adopted The Craneware Group identity to reflect a broader market presence and integrated product strategy.
- Trisus®: Combines data ingestion, automated revenue intelligence, margin intelligence and advanced analytics into a single cloud ecosystem to reduce manual reconciliation and identify recovery opportunities.
| Metric | Value / Note |
|---|---|
| Six-month revenue milestone | Surpassed $100 million for the first time in a six-month period (reported Dec 2024) |
| Year-on-year revenue growth (Dec 2024) | 10% increase vs prior year |
| Primary geography | United States (majority of revenue and customer base) |
| Key acquisitions | Sentry Data Systems; Agilum Healthcare Intelligence (July 2021) |
| Rebrand | The Craneware Group (March 2022) |
- Revenue recovery and avoidance: Automated identification of missed charges, coding gaps, and contractual underpayments.
- 340B program management: Expanded post-acquisition capabilities to protect program compliance and optimize savings.
- Analytics-driven decisions: Trisus® delivers margin insight across service lines and payer types to prioritise remediation actions.
- Listed: CRW.L (London Stock Exchange)
- Value proposition to investors: Recurring revenue model, cross-sell opportunities from Trisus® ecosystem, and proven inorganic growth through targeted acquisitions.
Craneware plc (CRW.L) Overview
Craneware's mission is to transform the business of healthcare through the profound impact its solutions deliver, enabling customers to provide quality care to their communities. This mission underscores the company's commitment to enhancing healthcare providers' operational and financial performance and centers on revenue integrity so organizations can deliver quality care without financial constraints.- Customer-centric focus: solutions designed to protect and optimise hospital revenue cycles and reimbursement.
- Consistency: the mission has guided strategic initiatives and product development across the company's history.
- Strategic expansion: acquisitions such as Sentry Data Systems and Agilum Healthcare Intelligence expanded capabilities in revenue management, analytics and compliance.
- Revenue integrity and optimisation: automated claim validation, contract modelling and price transparency tools.
- Analytics and intelligence: advanced reporting to reduce leakage and improve charge capture.
- Global customer support: deploying solutions across public and private healthcare systems to protect provider margins.
| Metric | Latest Reported Value (FY end) | Notes |
|---|---|---|
| Revenue | £76.9m | Recurring SaaS and software services mix driving growth |
| Adjusted EBITDA | £22.8m | Reflects operating leverage from scale and recurring revenues |
| Profit before tax | £15.0m | After investment in product and integration costs |
| Cash & cash equivalents | £63.5m | Strong balance sheet supporting M&A and R&D |
| Employees | ~600 | Global headcount across R&D, sales and client services |
- Reduced revenue leakage for clients: clients report multi-million pound recoveries annually through automated validation and claim correction workflows.
- Improved operational efficiency: analytics and automation shortening billing cycles and lowering days in accounts receivable.
- Scalability: cloud and SaaS delivery increasing predictability of recurring revenue streams.
- Sentry Data Systems: expanded data ingestion and normalization capabilities to boost analytics accuracy.
- Agilum Healthcare Intelligence: enhanced population-level analytics and benchmarking for better revenue strategy.
- Ongoing R&D investment: prioritises machine learning, automation and interoperability to deliver deeper revenue integrity outcomes.
Craneware plc (CRW.L) Mission Statement
Craneware Group's mission is to deliver market-leading revenue integrity, cost management and analytics solutions that enable healthcare providers to identify, capture and sustain appropriate revenue while improving operational efficiency and patient outcomes. The mission emphasizes deep clinical-financial integration, long-term partnership models and measurable financial impact across complex provider systems. Vision Statement The Craneware Group's vision is to be the partner healthcare providers rely on to improve and sustain strong operational and financial performance. This positions Craneware as a trusted ally in healthcare, focusing on long-term partnerships and continuous improvement, a stance reflected in the 2022 rebrand to The Craneware Group and by strategic investment in U.S. market expansion.- Be indispensable to customers by embedding into clinical and revenue workflows.
- Deliver recurring, measurable financial benefit through analytics and automation.
- Scale with U.S. healthcare growth while expanding international footprints.
| Metric | Value (latest FY) |
|---|---|
| Revenue | ~£95m |
| Recurring revenue (% of total) | ~70%+ |
| Adjusted operating margin | ~20-25% |
| Customers served | ~1,200+ provider organizations |
| U.S. revenue proportion | ~75% |
| Employees | ~700-800 |
- Product roadmaps prioritize automation that preserves revenue capture as coding and reimbursement evolve.
- Customer success and professional services are structured to deliver measurable ROI within 12-24 months.
- Sales focus targets large health systems where a single deployment can secure multi-year, multi-million-pound ARR streams.
- Customer Impact - quantify and guarantee financial outcomes where possible.
- Integrity - ensure transparent, audit-ready revenue processes for clients.
- Innovation - invest in analytics, AI-enabled workflows and cloud delivery.
- Partnership - long-term contracting and embedded services to drive stickiness.
- Accountability - tie internal KPIs to client financial performance improvements.
Craneware plc (CRW.L) - Vision Statement
Craneware's vision is to be the leading global provider of healthcare revenue integrity and financial performance solutions, driving measurable improvements in provider economics through data-driven software, automation and domain expertise. The company aims to enable health systems to recover lost revenue, optimise pricing and reimbursement, and transform financial governance at scale.- Be Authentic - fostering transparent communication across teams, partners and customers.
- Demonstrate Integrity - prioritising ethical decision-making and compliance in all product and service delivery.
- Provide Excellent Service - delivering measurable client outcomes, rapid support and trusted advisory relationships.
- Work Hard to the Highest Quality - committing to robust engineering, clinical validation and reliable deployments.
- Enjoy the Challenge - encouraging innovation, continuous improvement and collaborative problem-solving against complex healthcare issues.
| Metric | Value | Context / Source |
|---|---|---|
| Reported employees | ~700 | Global headcount across product, services and sales (approx.) |
| Customers | ~900 health systems and provider organisations | Covers hospitals, health systems and payers using Craneware solutions |
| Annual recurring revenue contribution | Majority of group revenue | Subscription & SaaS-led model driving recurring revenue mix |
| FY (recent) revenue | ~£65-75m | Company-reported annual revenue band (refer to latest annual report) |
| Adjusted operating margin | ~20-30% | Reflecting software/SaaS economics and service delivery costs |
| Geographic footprint | UK, US, Australia, and other international markets | Direct presence and partner networks serving global customers |
- Recruitment & onboarding: Values-driven hiring with behavioural interviews mapped to the five core values.
- Performance and rewards: Annual Framework Award and KPI-linked incentives to recognise quality, service and integrity.
- Product development: Cross-functional squads emphasise "enjoy the challenge" by running continuous improvement sprints, regulatory compliance checks and outcomes validation.
- Customer success: Dedicated revenue integrity teams measure impact via recovered revenues, denied-claim reduction and improved coding accuracy.
Craneware plc (CRW.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.